Response Genetics (Response Genetics) Days Sales Outstanding : 133.43 (As of Mar. 2015)

View and export this data going back to 2007. Start your Free Trial

What is Response Genetics Days Sales Outstanding?

Response Genetics's average Accounts Receivable for the three months ended in Mar. 2015 was $5.54 Mil. Response Genetics's Revenue for the three months ended in Mar. 2015 was $3.79 Mil. Hence, Response Genetics's Days Sales Outstanding for the three months ended in Mar. 2015 was 133.43.

The historical rank and industry rank for Response Genetics's Days Sales Outstanding or its related term are showing as below:

RGDXQ's Days Sales Outstanding is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 69.44
* Ranked among companies with meaningful Days Sales Outstanding only.

Response Genetics's Days Sales Outstanding declined from Mar. 2014 (137.69) to Mar. 2015 (133.43).

Response Genetics Days Sales Outstanding Historical Data

The historical data trend for Response Genetics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Response Genetics Days Sales Outstanding Chart

Response Genetics Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Days Sales Outstanding

Get a 7-Day Free Trial

70.77

91.75

320.24

201.38

117.85

Response Genetics Quarterly Data
	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Dec15
Days Sales Outstanding	Get a 7-Day Free Trial															128.52	137.12	-	133.43	-

Competitive Comparison of Response Genetics's Days Sales Outstanding

For the Diagnostics & Research subindustry, Response Genetics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Response Genetics's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Response Genetics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Response Genetics's Days Sales Outstanding falls into.

Response Genetics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Response Genetics's Days Sales Outstanding for the fiscal year that ended in Dec. 2015 is calculated as

	Days Sales Outstanding (A: Dec. 2015 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2014 )	+	Accounts Receivable (A: Dec. 2015 ))	/	count )	/	Revenue (A: Dec. 2015 )	*	Days in Period
=	( (5.028	+	6.621)	/	2 )	/	18.04	*	365
=	5.8245					/	18.04	*	365
=	117.85

Response Genetics's Days Sales Outstanding for the quarter that ended in Mar. 2015 is calculated as:

	Days Sales Outstanding (Q: Mar. 2015 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2014 )	+	Accounts Receivable (A: Mar. 2015 ))	/	count )	/	Revenue (A: Mar. 2015 )	*	Days in Period
=	( (5.028	+	6.059)	/	2 )	/	3.791	*	365 / 4
=	5.5435					/	3.791	*	365 / 4
=	133.43

Response Genetics (OTCPK:RGDXQ) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Response Genetics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Response Genetics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Response Genetics (Response Genetics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Response Genetics Inc (OTCPK:RGDXQ) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

201 Route 17 North, 2nd Floor, Rutherford, NJ, USA, 07070

Website

http://www.responsegenetics.com

Response Genetics Inc develops and sells diagnostic tests. It provides molecular- and biomarker-based tests and services which enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. The group generates revenue from providing Biopharma Services, Clinical Services, and Discovery Services, of which majority of the revenue is derived from providing Biopharma Services. Biopharma services provide companies with customized solutions for patient stratification and treatment selection through molecular- and biomarker-based testing services, customized assay development and trial design consultation. The firm operates in the US and internationally and generates prime revenue from the US.

Executives

Roberto Mignone	10 percent owner	C/O BRIDGER MANAGEMENT, LLC., 90 PARK AVENUE, 40TH FL., NEW YORK NY 10016
Bridger Management Llc	10 percent owner	90 PARK AVENUE, 40TH FLOOR, NEW YORK NY 10016
Swiftcurrent Offshore Ltd	10 percent owner	C/O MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, PO BOX 309, GRAND CAYMAN E9 KY1-1104
David Schreiber	director	15 TROTTERS LANE, MONROE CT 06468
Sam Chawla	director	1640 MARENGO STREET, 6TH FLOOR, LOS ANGELES CA 90033
Van Den Broek Richard	director	73 ARCH STREET, 1ST FLOOR, GREENWICH CT 06830
Kevin Roy Harris	officer: Vice President and CFO	345 N MAPLE DRIVE, SUITE 120, BEVERLY HILLS CA 90210
Kirk K Calhoun	director	8285 EL RIO STREET, SUITE 130, HOUSTON TX 77054
Michael Serruya	director	C/O RESPONSE GENETICS, INC., 1640 MARENGO ST., 6TH FLOOR, LOS ANGELES CA 90033
Thomas A Bologna	director, officer: Chief Executive Officer	4390 US ROUTE ONE, PRINCETON NJ 08540
Marxe Austin W & Greenhouse David M	10 percent owner	C/O SPECIAL SITUATIONS FUNDS, 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Partners Swiftcurrent	10 percent owner	90 PARK AVENUE, 40TH FLOOR, NEW YORK NY 10016
Bridger Capital Llc	10 percent owner	90 PARK AVENUE, 40TH FLOOR, NEW YORK NY 10016
Plc Glaxosmithkline	10 percent owner	980 GREAT WEST ROAD, BRENTFORD MIDDLESEX X0 TW8 9GS
Michael A Metzger	director	C/O SYNDAX PHARMACEUTICALS, INC., 400 TOTTEN POND ROAD,, WALTHAM MA 02451

Response Genetics (Response Genetics) Headlines

From GuruFocus

Response Genetics Inc. (RGDX) CFO Thomas Stankovich buys 7,000 Shares

By GuruFocus Research GuruFocus Editor • 12-14-2009

Response Genetics Inc. Reports Operating Results (10-Q)

By gurufocus • 05-15-2009

Response Genetics Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-09-2010

Response Genetics Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-16-2009

Response Genetics Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-22-2009

Response Genetics Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 05-14-2010